在多发性骨髓瘤的现实世界患者中一年内脆弱性分类的变化:前性队列研究 (MFRAIL)
Imran Haider1, Darryl P Leong2, Omar Shahid3
1Royal College of Surgeons in Ireland, Dublin, Ireland.
Clinical lymphoma, myeloma & leukemia
|October 5, 2025
概括
多发性骨髓瘤 (MM) 患者的脆弱性随着时间的推移而变化. 连续脆弱性得分比跟踪MM患者脆弱性动态的一次性评估更敏感.
科学领域:
- 老年学是指老年学的学科.
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 多发性骨髓瘤 (MM) 的脆弱性分布在基线已知.
- 有限的数据存在于MM患者的纵向脆弱性变化.
研究的目的:
- 评估MM患者在12个月内虚弱状态的动态变化.
- 为了比较不同脆弱性评估工具在检测这些变化的灵敏度.
主要方法:
- 纳入了116名MM患者 (新诊断或复发).
- 脆弱性在基线和12个月使用四种工具进行评估:IMWG,简化,梅奥和脆弱性指数.
- 分析了分类 (非脆弱,脆弱) 和连续脆弱性得分.
主要成果:
- 在各个指数中,虚弱状态的变化从13.8%到37.1%不等.
- 持续脆弱性得分的变化范围从20.7%到51.7%.
- 17.2%的患者表现出步行速度降低≥0.1m/s.
结论:
- MM患者的脆弱性是动态的,因此单一的基线测量可能不足.
- 与分类评估相比,连续脆弱性得分在检测微妙的脆弱性波动方面具有更高的灵敏度.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
187
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
187
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
196
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
196
Drug Dosing: Geriatric Patients
225
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
225
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
234
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
234
Bone Disorders
5.1K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.1K
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645


